OncoZenge AB (publ) (STO:ONCOZ)
Sweden
· Delayed Price · Currency is SEK 4.300
+0.020 (0.47%)
Apr 24, 2025, 4:49 PM CET
OncoZenge AB Revenue
In the year 2024, OncoZenge AB had annual revenue of 1,000.00 SEK, down -66.67%.
Revenue
1,000.00
Revenue Growth
-66.67%
P/S Ratio
50,366.95
Revenue / Employee
500.00
Employees
2
Market Cap
50.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000.00 | -2.00K | -66.67% |
| Dec 31, 2023 | 3.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Bonesupport Holding AB | 898.73M |
| AddLife AB | 10.29B |